Search
Selected: All

Treating vitamin D responsive diseases

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Treatment for hyperparathyroidism with use of vitamin D derivati

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Treatment of aging disorders in humans

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Treatment of arthritic disease induced by infectious agents

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Treatment of immune deficiency with vitamin D compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Treatment of myocardial failure

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Treatment of pruritus with vitamin D and analogs thereof

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Treatment of systemic lupus erythematosis

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Treatment of t-cell immunodeficiencies with vitamin D compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Tricycle steroid analogs

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Trifluorinated-1.alpha.,25S-dihydroxy vitamin D3 compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Trihydroxy-cholecacliferol and trihydroxy-ergocalciferol for tre

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of 1.alpha.-hydroxylated-19-nor-vitamin D compounds to treat

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of 2&agr;-methyl-19-nor-20(S)-1&agr;,...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of 2-methylene-19-nor-20(S)-1α,25-dihydroxyvitamin...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of 2-methylene-19-nor-20(S)-1α,25-dihydroxyvitamin...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of 2-methylene-19-nor-20(S)-1α,25-dihydroxyvitamin...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of 20(R)-22-oxa-vitamin D analogues for the treatment of ski

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of biologically active vitamin D compounds for the...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of biologically active vitamin D compounds for the...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0
  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.